Panel Discussion | Is Mitral Valve Repair for all Ready for Prime Time?

Saturday, March 7, 2026

3:58 PM - 4:18 PM EST

Location: Jefferson

Moderator(s)

Chirag Bavishi, MD, MPH

Director, Structural Heart Program
University of Missouri at Columbia

Disclosure(s): No financial relationships to disclose
Molly Szerlip, MD

Associate Medical Director, Education & Reserach and Regional Director, Sturctural Heart Progam
Baylor Scott and White The Heart Hospital Baylor Plano
Richardson, Texas, United States

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Advisory Board (Ongoing); Boston Scientific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CVI Foundation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); SCAI: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Hendrik Treede, MD

Director
University Heart and Vascular Center Mainz
Mainz, Rheinland-Pfalz, Germany

Disclosure information not submitted.

Panel Discussant(s)

Mehmet Cilingiroglu, MD

Professor
University of Hawaii John Burns School of Medicine
San Diego, California, United States

Disclosure(s): No financial relationships to disclose
Steven L. Goldberg, MD, FSCAI, FACC

Interventional Cardiologist
Three Crosses Regional Medical Center, Las Cruces, New Mexico
Monterey, California, United States

Disclosure information not submitted.
Homam Ibrahim, MD

Medical Director- Structural Heart Clinic
Adventist HealthCare White Oak Medical Center
Silver Spring, Maryland, United States

Disclosure(s): No financial relationships to disclose
Stephen H. Little, MD

Structural Heart Director
Houston Methodist Hosptial System
Houston, Texas, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Vlasis Ninios, MD

interventional cardiologist, Director of cardiology department
Interbalkan European Medical center
Thessaloniki , Greece

Disclosure(s): No financial relationships to disclose
Dimosthenis Pandis, MD

Assistant Professor, Cardiovascular Surgery, Assoc. Director, Clinical Research and Education
Ichan School of Medicine at Mount Sinai - The Mount Sinai Health System
New York, New York, United States

Disclosure(s): NIH/NHLBI: Grant/Research Support (Ongoing)
Martin Swaans, MD, PhD

Interventional Imager/Cardiologist
St.Antonius Hospital
Nieuwegein, Utrecht, Netherlands

Disclosure(s): AAbbott Vascular, Bioventrix inc., Boston Scientific, Cardiac Dimensions, Edwards Lifesciences, GE Healthcare, Medtronic, Philips Healthcare, P&F, Siemens Healthcare: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Chirag Bavishi, MD, MPH: No financial relationships to disclose

Molly Szerlip, MD: Abbott Vascular, Medtronic, Boston Scientific: Advisory Board (Ongoing); Boston Scientific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CVI Foundation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); SCAI: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Jeroen J. Bax, MD: Edwards, Abbott: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Mehmet Cilingiroglu, MD: No financial relationships to disclose

Homam Ibrahim, MD: No financial relationships to disclose

Vlasis Ninios, MD: No financial relationships to disclose

Dimosthenis Pandis, MD: NIH/NHLBI: Grant/Research Support (Ongoing)

Gregg W. Stone, MD, FACC, MSCAI: Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter, Vascentis: Stock-privately held company (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Consulting Fees (e.g., advisory boards) (Terminated); Colibri, Remote Cardiac Enablement, Valfix, Zoll, HeartFlow, Shockwave, Ancora, Adona Medical, Abbott, HighLife, Elucid Bio, Aria, Alleviant, FBR Medical, Bioventrix, MedHub, Biotyx Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave, Biosense-Webster, Bioventrix, Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Pulnovo, V-wave and PCORI via Weill Cornell Medical Center.: Grant/Research Support (Ongoing)